Group calls for ban on dolphin therapy

Oct 28, 2007

A British conservation group wants a ban on dolphin-assisted therapy, arguing there is no proof it helps the sick and disabled.

The Whale and Dolphin Conservation Society said that the therapy -- swimming with wild or captive dolphins -- involves "two highly vulnerable groups." In a report, the society cites studies that show the therapy can be dangerous.

"This is due to the fact that dolphins are wild animals and are unpredictable and that people have been injured swimming with dolphins, sometimes seriously," the group said in a statement. "Disease transmission is also a concern."

Dolphins have infected humans with brucellosis, while they have sometimes been infected with chickenpox after close contact with people.

As the therapy becomes more popular, dolphins are being taken into captivity to serve as therapy animals, the society said.

Copyright 2007 by United Press International

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

add to favorites email to friend print save as pdf

Related Stories

Dolphin 'therapy' a dangerous fad, Emory researchers warn

Dec 18, 2007

People suffering from chronic mental or physical disabilities should not resort to a dolphin "healing" experience, warn two researchers from Emory University. Lori Marino, senior lecturer in the Neuroscience and Behavioral ...

Recommended for you

Face transplants change lives, identity

13 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0